Yamynn DeAngelis
CVB FINANCIALAbout Yamynn DeAngelis
Executive Vice President and Chief Risk Officer (CRO) of Citizens Business Bank since January 5, 2009; age 68 as of FY2024, with prior roles in bank operations and service leadership from 1995–2008. As CRO, she participates in enterprise risk oversight to the Bank’s Risk Management Committee and coordinates with Audit and Compensation oversight structures, including chair-level management committees focused on compliance and compensation risk controls . Company performance context over her tenure includes cumulative TSR of 12% (1-year), 4% (3-year), and 4% (5-year) to December 31, 2024, and FY2024 net income of $200,716,000, with return on average tangible common equity (ROATCE) of 14.95% .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Citizens Business Bank | Executive Vice President, Chief Risk Officer | 2009–present | Enterprise risk management oversight; reporting to Board Risk Management Committee; coordination with Audit and Compensation risk governance processes |
| Citizens Business Bank | Executive Vice President, Service Division Manager | 2006–2008 | Service operations leadership; process and service delivery management |
| Citizens Business Bank | Senior Vice President, Division Service Manager | 1995–2005 | Operational leadership across service functions |
External Roles
No external public company directorships or outside board roles disclosed for DeAngelis in the 10-K/proxy materials reviewed .
Fixed Compensation
Not disclosed for DeAngelis (she is a Section 16 officer but not a named executive officer (NEO) in the 2024 CD&A); therefore, base salary and bonus specifics are not presented in the proxy .
Performance Compensation
Company PRSU design (applied to NEO grants; indicative of performance alignment mechanics used by the Compensation Committee):
| Metric | Weighting | Benchmark | Threshold (payout) | Target (payout) | Maximum (payout) | Measurement Window | Vesting |
|---|---|---|---|---|---|---|---|
| Relative ROAA | 50% | Percentile vs KBW Nasdaq Regional Banking Index (KRX) | 25th (75%) | 50th (100%) | 75th (125%, capped) | FY2024–FY2026 (3-year) | Scheduled on 3-year anniversary of Jan 24, 2024 grant (Jan 24, 2027) |
| Relative ROATCE | 50% | Percentile vs KBW Nasdaq Regional Banking Index (KRX) | 25th (75%) | 50th (100%) | 75th (125%, capped) | FY2024–FY2026 (3-year) | Scheduled on 3-year anniversary of Jan 24, 2024 grant (Jan 24, 2027) |
Notes:
- Dividend equivalents are paid on Time RSUs at declared dividend rates; PRSU dividend equivalents accrue and are paid retroactively upon determination of earned shares .
- The Compensation Committee emphasizes long-term compensation and company-wide performance to mitigate risk-taking, with oversight structures that include CRO involvement in compensation risk reviews .
Equity Ownership & Alignment
| Item | Status | Detail |
|---|---|---|
| Beneficial ownership (DeAngelis) | Not disclosed | Individual share count not presented; directors and current executive officers as a group owned 8,503,671 shares (6.1% of class) as of March 28, 2025; DeAngelis not broken out individually . |
| Hedging/derivatives | Prohibited without GC pre-clearance | Restricted Persons (includes NEOs and certain officers) are prohibited from short-selling, options trading, and hedging/monetization transactions without detailed justification and pre-clearance; as of proxy date, no known hedging positions by Restricted Persons . |
| Pledging/margin | Prohibited without GC pre-clearance | Pledging or margin placement requires written justification and pre-clearance; as of proxy date, no known pledged positions by Restricted Persons . |
| Rule 10b5-1 plans | None reported | As of proxy date, no known Rule 10b5-1 plans for directors or Section 16 officers . |
| RSU dividends | Yes (Time RSUs) | Dividend equivalents paid on Time RSUs at the same rate as quarterly dividends; PRSU dividend equivalents paid retroactively post-determination . |
| Section 16 compliance event | Late Form 4s (duplicate grant rescinded) | Two late Form 4 filings disclosed tied to an inadvertent duplicate annual equity award of 10,000 restricted shares to DeAngelis that was rescinded upon discovery . |
Employment Terms
| Provision | DeAngelis-Specific Disclosure | Company Policy Context |
|---|---|---|
| Employment agreement | Not disclosed | Form employment agreements covering NEOs include annual incentive eligibility and equity awards; DeAngelis not an NEO in 2024 CD&A . |
| Severance (non-CIC) | Not disclosed | NEO forms contemplate Committee discretion for severance if terminated without cause (case-by-case, release required) . |
| Change-in-control (CIC) | Not disclosed | NEO CIC: 2x base salary + 2x average bonus (preceding two years) paid over 18 months, plus 24 months COBRA equivalent; immediate vesting of unvested Time RSUs/options; PRSUs vest at target if <2 years completed, or based on actual performance if ≥2 years completed . |
| Death/disability | Not disclosed | NEO forms: immediate full vesting of unvested options, Time RSUs, PRSUs at target for incomplete periods . |
| Clawback | Adopted | Compensation Recoupment Policy compliant with Exchange Act Section 10D and Nasdaq 5608; applies to incentive comp tied to financial reporting measures on/after Oct 2, 2023 . |
| Deferred compensation | Plan available | Nonqualified Deferred Compensation Plan (2020 DCP) available to directors and certain specified officers; participant deferral elections and notional investment options; DeAngelis eligibility not specifically disclosed . |
Company Pay vs Performance (Context)
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total Shareholder Return (index base=100 at 12/31/2019) | 94.75 | 107.62 | 133.47 | 108.83 | 121.86 |
| Peer Group TSR (KBW Nasdaq Regional Banking Index) | 91.61 | 119.77 | 111.85 | 113.43 | 130.90 |
| Net Income ($) | 177,159,000 | 212,521,000 | 235,425,000 | 221,435,000 | 200,716,000 |
| ROATCE (%) | 14.25% | 15.93% | 18.85% | 18.48% | 14.95% |
Additional governance signals:
- Say-on-Pay approval was 91.75% in 2024; Compensation Committee does not expect significant changes to NEO program in 2025 .
- The company uses KRX peers for stock performance disclosure and pay-versus-performance benchmarking; Pearl Meyer advises the Compensation Committee on compensation peer analyses .
Investment Implications
- Alignment: CRO role embeds rigorous risk oversight into compensation governance; prohibition of hedging/pledging and absence of 10b5-1 plans among Restricted Persons reduce misalignment and selling pressure risk signals .
- Retention and succession: DeAngelis’s long tenure (CRO since 2009) and age 68 imply heightened succession planning importance for risk continuity; board structures and management committees emphasize continuity and risk controls .
- Compensation leverage: Company PRSU design ties long-term equity outcomes to relative ROAA/ROATCE vs KRX over three years, reinforcing pay-for-performance; however, DeAngelis’s individual grant history, targets, and severance/CIC economics are not disclosed, limiting direct pay-risk assessment at the person level .
- Controls: A disclosed administrative error (duplicate restricted stock grant to DeAngelis that was rescinded) resulted in late Form 4s; remediation suggests control awareness, but it is a governance footnote to monitor for process robustness .